Literature DB >> 15218191

CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1.

Patrick M Stuart1,2, Brett Summers1,2, Jessica E Morris2, Lynda A Morrison3, David A Leib1,2.   

Abstract

The role that T cell subsets play in herpetic stromal keratitis (HSK) has been the subject of intense research efforts. While most studies implicate CD4(+) T cells as the principal cell type mediating primary corneal disease, recent reports using knockout mice have suggested that both CD4(+) and CD8(+) T cell subsets may play integral roles in modulating the disease. Furthermore, recent studies suggest that CD8(+) T cells are directly involved in maintaining virus latency in infected trigeminal ganglia. This work has addressed these discrepancies by infecting the corneas of mice lacking CD4(+) and CD8(+) T cells with herpes simplex virus type 1 (HSV-1) and monitoring both corneal disease and latent infection of trigeminal ganglia. Results indicated that mice lacking CD8(+) T cells had more severe corneal disease than either BALB/c or B6 parental strains. In contrast, mice lacking CD4(+) T cells had a milder disease than parental strains. When mice were evaluated for persistence of infectious virus, only transient differences were observed in periocular tissue and corneas. No significant differences were found in persistence of virus in trigeminal ganglia or virus reactivation from explanted ganglia. These data support the following conclusions. CD4(+) T cells are not required for resistance to infection with HSV-1 and probably mediate HSK. Mice lacking CD8(+) T cells do not display differences in viral loads or reactivation and thus CD8(+) T cells are not absolutely required to maintain latency. Finally, CD8(+) T cells probably play a protective role by regulating the immunopathological response that mediates HSK.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218191     DOI: 10.1099/vir.0.80049-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  34 in total

1.  CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.

Authors:  Christopher D Conrady; Min Zheng; Donald U Stone; Daniel J J Carr
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

2.  CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice.

Authors:  Andrew J Lepisto; Gregory M Frank; Min Xu; Patrick M Stuart; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

3.  Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.

Authors:  Lbachir BenMohamed; Nelson Osorio; Ruchi Srivastava; Arif A Khan; Jennifer L Simpson; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-05-22       Impact factor: 2.643

Review 4.  Immune regulation of multiple sclerosis by CD8+ T cells.

Authors:  Sushmita Sinha; Farah R Itani; Nitin J Karandikar
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 5.  Asymptomatic memory CD8+ T cells: from development and regulation to consideration for human vaccines and immunotherapeutics.

Authors:  Arif Azam Khan; Ruchi Srivastava; Patricia Prado Lopes; Christine Wang; Thanh T Pham; Justin Cochrane; Nhi Thi Uyen Thai; Lucas Gutierrez; Lbachir Benmohamed
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

6.  CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.

Authors:  Devin M West; Chelsea R Del Rosso; Xiao-Tang Yin; Patrick M Stuart
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

7.  Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopes.

Authors:  Rebecca L Sanchez; Alistair J Ramsay; Timothy P Foster
Journal:  J Virol Methods       Date:  2011-10-20       Impact factor: 2.014

8.  CXCL9 compensates for the absence of CXCL10 during recurrent Herpetic stromal keratitis.

Authors:  Deena Tajfirouz; Devin M West; Xiao-Tang Yin; Chloe A Potter; Robyn Klein; Patrick M Stuart
Journal:  Virology       Date:  2017-03-07       Impact factor: 3.616

9.  Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.

Authors:  Ruchi Srivastava; Arif A Khan; Sumit Garg; Sabrina A Syed; Julie N Furness; Hawa Vahed; Tiffany Pham; Howard T Yu; Anthony B Nesburn; Lbachir BenMohamed
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

10.  A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo.

Authors:  Gilbert G Jose; Inna V Larsen; Joshua Gauger; Erica Carballo; Rebecca Stern; Rachel Brummel; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.